Lipid nanoparticles for mRNA delivery

Explore this paper's citation graph

Summary

Lipid nanoparticles have successfully entered the clinic for the delivery of mRNA and lipid nanoparticle–mRNA vaccines are now in clinical use against coronavirus disease 2019 (COVID-19), which marks a milestone for mRNA therapeutics.

Type
review
Published
2021-08-10
Cited by
3,399
References
260
Access
Open access

Keywords

Messenger RNA, Translation (biology), Nanoparticle, Nucleic acid, RNA

References

Cited by

Related papers